Only GE brings the power of 3C imaging to nuclear medicine with Volumetrix Suite. Volumetrix 3D produces integrated, three-dimensional fused images within the nuclear medicine workflow, offering more clarity for more intuitive and faster interpretation,” said Gene Saragnese, vice president and general manager of molecular imaging for GE Healthcare. “Volumetrix IR offers clinicians the choice of virtually any CT to view registered to SPECT and PET data, together with automatic registration and easy export options. This combination offers clinicians outstanding convenience, capability and value.
Volumetrix 3D benefits the clinician by offering improved clarity: helping to manage large amounts of data more effectively by providing an accurate, interactive, 3D rendered fused image of the entire nuclear medicine study. Volumetrix 3D’s segmentation tools can help improve diagnostic accuracy by easily removing obstructions surrounding lesions and other areas of interest. Volumetrix 3D also offers a Clip and Cut Planes feature, which allows the anatomy to be “virtually sliced” to show the underlying cross-section of the CT, nuclear or fused slices. The software presents a visual abstract of the exam very quickly and comprehensively for use by the referring physician or surgeon.
Volumetrix IR offers clinicians the choice of registering virtually any CT to the Infinia SPECT data, within the nuclear medicine workflow. This feature eliminates the need for patients to undergo a redundant full-dose CT exam during a SPECT acquisition by using the Hawkeye CT as a guide to register an external CT to the Infinia SPECT data. Volumetrix IR is designed to offer a balanced solution for today’s challenging healthcare economic environment. By offering registration of virtually any CT with Infinia Hawkeye 4 data, Volumetrix IR presents the clinician with more choices while minimizing ownership costs.
The Volumetrix Suite is designed to provide users outstanding convenience as well. Follow-up scans are made easier as Volumetrix IR aligns two exams, helping to ensure accurate monitoring of the patient’s condition. Three-dimensional rendered images created by Volumetrix 3D are easily exported into a variety of formats including .jpg files for easy sharing with referring physicians, surgeons and the patients themselves.
“Volumetrix is a tremendous step forward in helping our customers prepare for the next frontier in molecular imaging,” said Nathan Hermony, nuclear medicine general manager, GE Healthcare. “We believe that Volumetrix Suite will bring clinicians the power of three C imaging: Clarity, Choice, and Convenience.”
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at http://www.gehealthcare.com
For More Information Contact
GE Healthcare, Americas